Roche’s diabetes app recalled over software bug: 4 things to know

Roche Diabetes Care recalled its Accu-Chek Connect diabetes management app over software issues, according to an FDA safety alert issued Feb. 15.

Advertisement

1. Certain iOS and Android versions of the app contain a software bug that causes the unit of measure for blood glucose to change. “This creates a risk the app might not transfer the blood glucose result or the user might not correctly input numerical values for carbohydrate used for bolus advice,” the agency said in the alert.

2. Roche posted about the software bug on its Accu-Chek website June 13 and rolled out an updated version of the app to fix the bug.

3. Roche recommends users clear all data from their Accu-Chek blood glucose meter before pairing the device with the mobile app for the first time after updating.

4. The FDA said about 67,040 people were still using the older version of the app, as of Feb. 15.

More articles on supply chain:

FDA greenlights extended-release Parkinson’s drug: 4 things to know
Novartis looks to auction off US generics business: 4 takeaway
AstraZeneca’s immunotherapy drug OK’d for lung cancer: 5 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.